Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics

Statistical Principles in Experimental Design

Jerome L. Myers, B. J. Winer · The American Journal of Psychology · 1964 · 8.1K citations

Public Health, Biostatistics, Experimental Design +10

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Ian Creese, David R. Burt, Solomon H. Snyder · Science · 1976 · 2.2K citations

Medicine, Neuroscience, Pharmacology +14

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

J.C. Stoof, John W. Kebabian · Nature · 1981 · 917 citations

Life Sciences, Neurobiology, Neuroscience +16

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Louis C. Iorio, A Barnett, Frederick H. Leitz et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 897 citations

Medicine, Pharmacology, Psychiatry +15

SCH 23390—The first selective dopamine D-1 antagonist

John Hyttel · European Journal of Pharmacology · 1983 · 739 citations

Medicine, Neuroscience, Pharmacology +13